Shane Olwill
Corporate Officer/Principal en PIERIS PHARMACEUTICALS, INC. .
Fortuna: 849 $ al 31/03/2024
Perfil
Shane Olwill is currently the Chief Development Officer & Senior Vice President at Pieris Pharmaceuticals, Inc. He previously worked as a Research Director at Fusion Antibodies Plc.
Dr. Olwill holds a doctorate degree from the University of Ulster.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/02/2023 | 4 638 ( 0.00% ) | 849 $ | 31/03/2024 |
Cargos activos de Shane Olwill
| Empresas | Cargo | Inicio |
|---|---|---|
| PIERIS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Antiguos cargos conocidos de Shane Olwill.
| Empresas | Cargo | Fin |
|---|---|---|
| FUSION ANTIBODIES PLC | Chief Tech/Sci/R&D Officer | - |
Formación de Shane Olwill.
| University of Ulster | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| FUSION ANTIBODIES PLC | Health Services |
| PIERIS PHARMACEUTICALS, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Shane Olwill
